Stock Price
52.26
Daily Change
0.99 1.93%
Monthly
31.08%
Yearly
102.79%
Q1 Forecast
12.72

Phibro Animal Health reported $862.18M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Align Technology USD 2.62B 82.47M Dec/2025
ANI Pharmaceuticals USD 698.4M 95.77M Sep/2025
Assertio Holdings USD 263.57M 53.36M Sep/2025
Aurora Cannabis CAD 423.84M 41.46M Sep/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Canopy Growth CAD 445.82M 142.46M Sep/2025
Corcept Therapeutics USD 541.13M 98.02M Sep/2025
Eli Lilly USD 55.63B 6.44B Dec/2025
Henry Schein USD 4.4B 152M Sep/2025
Idexx Laboratories USD 1.41B 63.23M Dec/2025
Knight Therapeutics CAD 397.57M 36.96M Sep/2024
Merck USD 47.56B 10.49B Sep/2025
Nektar Therapeutics USD 281.36M 94.79M Sep/2025
Pacira USD 562.75M 182.86M Sep/2025
Phibro Animal Health USD 862.18M 26.39M Dec/2025
Prestige Brands USD 433.43M 63.98M Dec/2025
Supernus Pharmaceuticals USD 593.89M 144.98M Sep/2025
Zoetis USD 6.77B 185M Dec/2025